Study of Current and New Drugs in a Murine Model of Acute Paracoccidioidomycosis

Eli Lefler Division of Infectious Diseases, Department of Medicine and Clinical Microbiology Laboratory, Department of Pathology, Santa Clara Valley Medical Center, Stanford University, and Institute for Medical Research, San Jose, California 95128

Search for other papers by Eli Lefler in
Current site
Google Scholar
PubMed
Close
,
Elmer Brummer Division of Infectious Diseases, Department of Medicine and Clinical Microbiology Laboratory, Department of Pathology, Santa Clara Valley Medical Center, Stanford University, and Institute for Medical Research, San Jose, California 95128

Search for other papers by Elmer Brummer in
Current site
Google Scholar
PubMed
Close
,
Juan G. McEwen

Search for other papers by Juan G. McEwen in
Current site
Google Scholar
PubMed
Close
,
Guillermo L. Hoyos

Search for other papers by Guillermo L. Hoyos in
Current site
Google Scholar
PubMed
Close
,
Angela Restrepo Laboratory of Mycology, Corporacion de Investigaciones Biológicas, Hospital Pablo Tobon Uribe, Medellín, Colombia

Search for other papers by Angela Restrepo in
Current site
Google Scholar
PubMed
Close
, and
David A. Stevens Division of Infectious Diseases, Department of Medicine and Clinical Microbiology Laboratory, Department of Pathology, Santa Clara Valley Medical Center, Stanford University, and Institute for Medical Research, San Jose, California 95128

Search for other papers by David A. Stevens in
Current site
Google Scholar
PubMed
Close
Restricted access

A new murine model of acute paracoccidioidomycosis, whose features include pulmonary infection with dissemination, was used to study the efficacy of currently available drugs and new agents which might be useful clinically. Two oral imidazole drugs, ketoconazole (KTZ) and Bay l 9139 (l9); two oral triazoles, Bay n 7133 (n7) and ICI 153,066 (ICI); and two polyenes, amphotericin B (AMB) and N-D-ornithyl-amphotericin B methyl ester, were studied. KTZ was superior to n7 and l9, particularly after a less lethal challenge. The polyenes could diminish dissemination, but had only modest effects on the pulmonary infection; AMB appeared slightly more effective. ICI was the most effective drug studied, approximately 5–10 times more potent than KTZ on a milligram/kg body weight basis; it had marked effects on both pulmonary and disseminated disease. These initial applications of the model to therapeutic evaluation suggest sufficient flexibility and utility, with information obtainable after relatively short experiments.

Author Notes

Save